ArcticZymes Technologies launches share buyback for employee incentive program

ArcticZymes Technologies ASA has initiated a share buyback program, authorized by its Annual General Meeting on May 27, 2025, to support share-based incentive programs. This allows employees and management to acquire shares at a 15% discount from the market price. The program will acquire a maximum of 31,365 shares for up to NOK 3.1 million, with individual share prices ranging from NOK 1.00 to NOK 100.00.

The buyback will be conducted on the Oslo Stock Exchange between November 25, 2025, and December 5, 2025, with DNB Carnegie acting as the independent executor. This program adheres to EU Market Abuse Regulation (MAR) and Commission Delegated Regulation (EU) 2016/1052, providing a "safe harbour."

The company, headquartered in Tromsø, Norway, is a publicly listed provider of high-quality enzymes for molecular research, diagnostics, and biomanufacturing. The authorization permits the board to acquire up to 5% of the company's share capital.